Gthp.Pk
GTHP.PK operates in the Advanced Medical Equipment & Technology industry, providing specialized healthcare services and equipment.
Business. GTHP.PK operates in the Advanced Medical Equipment & Technology industry, providing specialized healthcare services and equipment.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Company
- EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
GTHP.PK operates in the Advanced Medical Equipment & Technology industry, providing specialized healthcare services and equipment.
GTHP.PK exhibits a highly leveraged capital structure, with total liabilities of $7.33 million and total equity of -$6.01 million, resulting in a negative debt-to-equity ratio of -0.37. The company's liquidity position is weak, with a current ratio of 0.09 and only $63,000 in cash and equivalents. This suggests a high liquidity risk, as the company may struggle to meet short-term obligations without external financing.
Profitability metrics are severely negative, with a net loss of $3.196 million and an operating loss of $2.809 million. The return on equity of 53.21% is misleading due to the negative equity base, and the return on assets of -2.41% indicates poor asset utilization. These figures fall well below the industry median for profitability and returns, highlighting a significant underperformance relative to peers.
The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to sector-specific risks and limits growth opportunities. There is no available data on geographic revenue distribution, but the absence of segment reporting suggests a high concentration risk.
GTHP.PK's growth trajectory is uncertain, with no disclosed revenue growth or outlook provided in the available data. The company reported a revenue of $767,000, but without historical comparisons or forward-looking guidance, it is difficult to assess future performance. The negative operating and net income figures suggest a lack of sustainable growth drivers.
The risk assessment indicates a medium liquidity risk and a low dilution risk. The company's negative net cash position after subtracting total debt is a key flag, suggesting potential cash flow constraints. There is no indication of recent dilutive events, and the diluted shares outstanding are equal to the basic shares, indicating no near-term dilution pressure.
Recent events and filings are not disclosed in the available data, making it difficult to assess any material developments or strategic shifts. The absence of recent transcripts or filings limits the ability to evaluate management's strategy or operational performance.
- GTHP.PK has a highly leveraged capital structure with a negative equity position and weak liquidity.
- The company is unprofitable, with significant operating and net losses, and underperforms industry peers on key profitability metrics.
- Revenue is concentrated in a single segment, with no geographic diversification disclosed, increasing exposure to sector-specific risks.
- Growth prospects are unclear due to the lack of historical revenue data and forward-looking guidance.
- Liquidity risk is medium, and dilution risk is low, but the company's negative net cash position is a key concern.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- GTHP.PK Market data — financials · 2026-05-28
Ownership & reference
Leadership
- Mark L. FaupelPresident, Chief Executive Officer, Director
Insider activity
Short positioning
Geographic breakdown
Intel & risk
Evidence & claims
From filings & derived data- Return on equity (FY 2025-12-31): 53.2%Derived (calculated)
- Gross margin (FY 2025-12-31): 74.4%Derived (calculated)
- Net margin (FY 2025-12-31): -416.7%Derived (calculated)
- EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): 20.0%Derived (calculated)
- Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): 4.6%Derived (calculated)
- Gross profit (YoY) (2025-12-31 vs 2024-12-31): 28,450.0%Derived (calculated)
- Net income (YoY) (2025-12-31 vs 2024-12-31): -32.2%Derived (calculated)
- Cost of revenue (YoY) (2025-12-31 vs 2024-12-31): 3,820.0%Derived (calculated)
- EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): 20.0%Derived (calculated)
- Debt-to-equity (FY 2025-12-31): -1.22xDerived (calculated)
- Current ratio (FY 2025-12-31): 0.09xDerived (calculated)
- Return on assets (FY 2025-12-31): -241.4%Derived (calculated)
- Operating income (YoY) (2025-12-31 vs 2024-12-31): -12.5%Derived (calculated)
- Revenue (YoY) (2025-12-31 vs 2024-12-31): 10,857.1%Derived (calculated)
- Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): -22.8%Derived (calculated)
- Total assets (YoY) (2025-12-31 vs 2024-12-31): -3.9%Derived (calculated)
- Total liabilities (YoY) (2025-12-31 vs 2024-12-31): 17.0%Derived (calculated)
- R&D expense (YoY) (2025-12-31 vs 2024-12-31): -10.8%Derived (calculated)
- Capex (annual): USD 2KSEC XBRL filing
- Shareholders' equity (annual): USD -6.01MSEC XBRL filing
- EPS (basic) (annual): USD-PER-SHARES -0SEC XBRL filing
- R&D expense (annual): USD 469KSEC XBRL filing
- Operating cash flow (annual): USD -1.07MSEC XBRL filing
- Revenue (annual): USD 767KSEC XBRL filing